Ali Fattaey
Chief Operating and Scientific Officer
Department of drug discovery
ACT Biotech Inc
United States of America
Biography
Dr. Fattaey has been engaged in cancer research, drug discovery and development for the past 17 years. Most recently Dr. Fattaey served as Chief Scientific Officer of Sagres Discovery from 2002 through 2005 where he led the discovery and development of anti-cancer therapeutics using Sagres’ proprietary Oncogenome™ technology. Dr. Fattaey later joined Chiron Corporation upon its acquisition of Sagres Discovery in late 2004. Prior to Sagres, Dr. Fattaey joined Onyx Pharmaceuticals in 1994 where he served as the Vice President of Discovery Research from 1998 to 2001. Dr. Fattaey has been engaged in cancer research, drug discovery and development for the past 17 years. Most recently Dr. Fattaey served as Chief Scientific Officer of Sagres Discovery from 2002 through 2005 where he led the discovery and development of anti-cancer therapeutics using Sagres’ proprietary Oncogenome™ technology. Dr. Fattaey later joined Chiron Corporation upon its acquisition of Sagres Discovery in late 2004. Prior to Sagres, Dr. Fattaey joined Onyx Pharmaceuticals in 1994 where he served as the Vice President of Discovery Research from 1998 to 2001.
Research Interest
Drug discovery
